Clinical Trial Update: Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of erenumab on blood pressure when given with subcutaneous sumatriptan in healthy subjects has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Subjects

Drugs mentioned

• Sumatriptan (Sumatriptan)
• erenumab (erenumab)

Snippet

Sponsor: Amgen | Conditions: Healthy Subjects | Phase 1 | Status: COMPLETED | Results posted: 2019-03-05